Mayo Clinic and Merck Collaborate to Advance AI-Powered Healthcare

Partnership leverages clinical data and virtual cell technologies to accelerate drug discovery and personalize treatment plans

Published on Feb. 23, 2026

Got story updates? Submit your updates here. ›

Mayo Clinic and Merck have announced a groundbreaking collaboration to transform patient care through the power of artificial intelligence (AI) and data analytics. The partnership will leverage Mayo Clinic Platform, a secure environment designed to harness vast amounts of clinical and genomic data, along with Merck's AI and machine learning capabilities, to enhance disease understanding and identify promising drug targets.

Why it matters

This collaboration represents a significant step forward in the convergence of AI and healthcare, promising to accelerate drug discovery, personalize treatment plans, and improve patient outcomes. By combining Mayo Clinic's clinical insights and data with Merck's AI expertise, researchers can develop more accurate and efficient virtual cell models to study disease mechanisms and predict the effects of potential drugs.

The details

The partnership will integrate clinical and genomic data from Mayo Clinic's international network with Merck's own AI and machine learning research capabilities. This will enable the analysis of vast amounts of data to identify patterns and insights that would be impossible to detect manually, particularly in areas like cancer, cardiovascular disease, and gastroenterology. Additionally, the collaboration will focus on leveraging AI-enabled virtual cell technologies, which involve creating computer simulations of cells to study disease and test potential drugs.

  • The partnership was announced on February 18, 2026.
  • Mayo Clinic Platform_Insights, a program to make AI more accessible to healthcare providers, was launched in November 2025.

The players

Mayo Clinic

A nonprofit organization committed to clinical practice, education, and research. Mayo Clinic is consistently ranked among the top hospital systems in the world, recognized for its innovation and patient care.

Merck

A global healthcare company that develops and produces a wide range of medicines, vaccines, and other health products.

Got photos? Submit your photos here. ›

What’s next

The partnership between Mayo Clinic and Merck is expected to accelerate drug discovery and personalize treatment plans, with a focus on areas like cancer, cardiovascular disease, and gastroenterology.

The takeaway

This collaboration between Mayo Clinic and Merck highlights the transformative potential of AI and data analytics in healthcare, promising to revolutionize drug discovery, personalize treatment, and ultimately improve patient outcomes. By leveraging their respective strengths, the two organizations are paving the way for a future where AI-powered solutions become an integral part of the healthcare landscape.